Indaptus Therapeutics, Inc.
INDP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $6 | $144 | $221 |
| - Cash | $6 | $6 | $4 | $6 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | -$0 | $140 | $215 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$5 | -$5 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$5 | -$5 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.98 | -9.1 | -0.48 | -0.38 |
| % Growth | 67.3% | -1,795.8% | -26.3% | – |
| Operating Cash Flow | -$3 | -$4 | -$5 | -$3 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3 | -$4 | -$5 | -$3 |